Project Grant R21CA290430

Award Date 6/1/24
Completion Date 5/31/26
Dollars Obligated $397K
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will provide $156,500 to the University of Missouri System to explore patterns of self-reported breast cancer-related lymphedema (BCRL) symptoms and associated lifestyle/health factors among nurses who are breast cancer survivors. The researchers will analyze five biennial waves of survey data from the Nurses' Health Study, a large national longitudinal database, to: 1) examine...
This $162,190 Project Grant award from the National Institute of Nursing Research (CFDA 93.361 Nursing Research) aims to examine the feasibility, acceptability, and preliminary efficacy of a peer-led, web-based support intervention to reduce distress and improve health-related quality of life among Black breast cancer survivors. The key products and services to be delivered under this 3-year award include: 1) Establishing a community advisory board to collaborate on all phases of the study, 2)...
This Project Grant award, funded by the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398), supports the development and evaluation of a virtual, group-based expressive writing intervention for adolescent and young adult cancer survivors (AYACSS). The $161,432 grant, awarded on September 1, 2024, aims to enhance the quality of life and reduce stress for AYACSS, who face disparities in psychosocial health, isolation, and limited access to support services. The...
This $215,985 Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) aims to develop a culturally adapted, behavioral intervention called SAFAD (South Asian Family Approaches to Disease) to improve self-management and mitigate stress, loneliness, and social isolation among South Asian breast cancer survivors and their caregivers. The funding will be used by The Leland Stanford Junior University to culturally adapt their existing...
The National Center for Advancing Translational Sciences (NCATS), a program under the Department of Health and Human Services, has awarded a $173,500 Project Grant (CFDA 93.350) to Health Research, Inc. to conduct research on the role of interferon and interferon-regulated chemokines in stress-induced immunosuppression in triple negative breast cancer. The funding will support a 2-year study that aims to investigate a novel mechanistic pathway of how chronic stress and its mediators can...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This federal Project Grant award from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) provides $1,165,096 to the Sloan-Kettering Institute for Cancer Research to investigate the social genomic mechanisms linking structural racism, perceived discrimination, and breast cancer survival. The key products and services to be delivered under this 5-year award include: 1) defining the contributions of objective structural...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), provides $402,600 to the Fred Hutchinson Cancer Center in Seattle, Washington to conduct research on disparities in financial and clinical outcomes among commercially-insured cancer patients following the implementation of the Affordable Care Act (ACA). The key objectives of this 4-year study are to: 1) Understand how the characteristics of...
This federal Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research (CFDA 93.307) program, provides $842,625 to study the association between cumulative stress and DNA methylation among Ethiopian American immigrants (EAIs). The study aims to 1) measure the cumulative stress burden and identify stress burden profiles among EAIs, and 2) determine the association between cumulative stress and DNA...
This Project Grant award, funded by the National Cancer Institute (CFDA 93.396 Cancer Biology Research), will support research to investigate the biological mechanisms underlying racial disparities in head and neck cancer outcomes, particularly among Black patients. The $714,062 award to the Regents of the University of California, San Francisco, with a project period from Apr 2025 to Mar 2030, has two key objectives: Develop a prognostic model using gene expression signatures to predict...

STRESS, INFLAMMATION, AND HEALTH-RELATED QUALITY OF LIFE OF LONG-TERM BREAST CANCER SURVIVORS - A BREAST CANCER (BC) DIAGNOSIS IS A SIGNIFICANT LIFE EVENT THAT CAN ADVERSELY IMPACT HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN BC SURVIVORS BY INDUCING MAJOR STRESS ASSOCIATED WITH DIAGNOSIS AND TREATMENT OVER THE SHORT-TERM. OVER THE LONG-TERM, BC SURVIVORS CAN ALSO EXPERIENCE MAJOR STRESS ASSOCIATED WITH PERSISTENT SYMPTOMS AND TREATMENT-RELATED LATE EFFECTS, AS WELL AS RELATED PSYCHOLOGICAL, SOCIAL, AND FINANCIAL STRESS THAT PERSIST LONG INTO SURVIVORSHIP, ADVERSELY AFFECTING HRQOL IN LONG-TERM BC SURVIVORS. THERE IS GROWING EVIDENCE THAT IN ADDITION TO THESE INDIVIDUAL-LEVEL STRESSORS, NEIGHBORHOOD-LEVEL STRESSORS OF THE SOCIAL AND BUILT ENVIRONMENTS ALSO ADVERSELY IMPACT CANCER SURVIVORSHIP OUTCOMES, INCLUDING HRQOL. MOST PRIOR STUDIES OF HRQOL, HOWEVER, EXAMINED INDIVIDUAL-LEVEL STRESSORS ONLY AND WERE FOCUSED ON SHORT-TERM BC SURVIVORS, PRIMARILY FROM NON- HISPANIC WHITE (NHW) POPULATIONS. THERE IS A SIGNIFICANT GAP IN KNOWLEDGE ABOUT MULTI-LEVEL STRESSORS THAT ADVERSELY IMPACT HRQOL AMONG LONG-TERM BC SURVIVORS, AND IT IS NOT KNOWN WHETHER KEY STRESSORS DIFFER AMONG SURVIVORS FROM DIFFERENT RACIAL AND ETHNIC MINORITIZED (REM) AND IMMIGRANT POPULATIONS WHO LIKELY HAVE A GREATER BURDEN OF BOTH INDIVIDUAL-LEVEL AND NEIGHBORHOOD-LEVEL STRESSORS. WE WILL CONDUCT THE R21 PILOT STUDY IN THE NORTHERN CALIFORNIA BREAST CANCER FAMILY REGISTRY (NC-BCFR), A PROSPECTIVE POPULATION-BASED COHORT ENRICHED WITH AFRICAN AMERICAN, ASIAN AMERICAN, AND HISPANIC WOMEN WITH INCIDENT BC DIAGNOSED FROM 1995-2009 WHO HAVE BEEN ACTIVELY FOLLOWED FOR 14-28 YEARS SINCE DIAGNOSIS. FROM THE 1,116 ACTIVE LONG-TERM BC SURVIVORS WHO COMPLETED THE LATEST FOLLOW-UP (2019-2022), WE WILL SELECT A REPRESENTATIVE SAMPLE OF BC SURVIVORS WHO SELF- IDENTIFIED AS AFRICAN AMERICAN, ASIAN AMERICAN, OR HISPANIC. WE WILL COLLECT QUESTIONNAIRE DATA ONLINE OR BY PHONE INTERVIEW ON HRQOL, INDIVIDUAL-LEVEL STRESSORS (CANCER-SPECIFIC AND SOCIAL STRESSORS), AND UPDATED SOCIODEMOGRAPHIC CHARACTERISTICS FOR 270 PARTICIPANTS (90 AFRICAN AMERICAN, 90 ASIAN AMERICAN, 90 HISPANIC SURVIVORS). USING GEOSPATIAL DATA FROM THE AMERICAN COMMUNITY SURVEY, WE WILL APPEND CENSUS-TRACT LEVEL NEIGHBORHOOD CHARACTERISTICS AND DERIVE SOCIAL NEIGHBORHOOD-LEVEL STRESSORS TO GEOCODED ADDRESSES. WE WILL COLLECT BLOOD SAMPLES FOR 176 PARTICIPANTS AND MEASURE C-REACTIVE PROTEIN (CRP) AND A PANEL OF CYTOKINES TO EXPLORE ASSOCIATIONS WITH MULTI-LEVEL STRESSORS AND WITH HRQOL. IN AIM 1, WE WILL EXPLORE ASSOCIATIONS BETWEEN MULTI-LEVEL STRESSORS AND HRQOL AND IDENTIFY KEY STRESSORS IN EACH RACIAL, ETHNIC, AND NATIVITY GROUP. IN AIM 2, WE WILL ASSESS VARIATION IN INFLAMMATORY BIOMARKERS BY MULTI-LEVEL STRESSORS AND BY HRQOL. THE FINDINGS FROM THIS R21 PILOT STUDY WILL INFORM THE DESIGN OF A LARGER STUDY OF STRESS, INFLAMMATION, AND HRQOL AMONG LONG-TERM BC SURVIVORS. THE IDENTIFICATION OF SPECIFIC LONG-TERM BC SURVIVOR GROUPS WITH LOW HRQOL AND SPECIFIC STRESSOR PROFILES WILL INFORM SURVIVORSHIP CARE AND LAY THE FOUNDATION FOR FUTURE TARGETED MULTI-LEVEL STRATEGIES AND INTERVENTIONS TO REDUCE MULTI-LEVEL STRESSORS AND IMPROVE HRQOL IN ALL RACIAL, ETHNIC, AND NATIVITY GROUPS OF BC SURVIVORS, WITH THE ULTIMATE GOAL OF ACHIEVING HIGH HRQOL, IMPROVED SURVIVAL, AND HEALTH EQUITY FOR ALL SURVIVORS.

Posted 5/20/24, 12:00 AM